clinical trial · NCT06067841
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Bristol-Myers Squibb·phase1·recruiting·n = 140
Metastatic Castration-resistant Prostate CancerBMS-986460
brief summary
The purpose of this study is to assess the safety, tolerability, and preliminary efficacy of BMS-986460 in men with Metastatic Castration-resistant Prostate Cancer.
started
Oct 18, 2023
primary completion
Aug 24, 2029
completion
Jul 27, 2031
last updated
Feb 4, 2026
official title
A Phase 1, Open-label Study of BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol